EST
XBIT icon

EA Series Trust’s XBiotech XBIT Stock Holding History

EA Series Trust’s Portfolio XBIT Stock Details XBIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		$296K Buy
+49,776
New +$225K 0.01% 966

Other funds holding XBIT

Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

EA Series Trust's XBIT Position: Q2 2023 in Review

EA Series Trust opened a new position in XBiotech (XBIT) in Q2 2023: 49,776 shares worth $296K. The stake represents 0.01% of the portfolio and ranks #966 among its holdings.

39 funds tracked by Wall St. Rank hold XBIT as of Q2 2023.

  • EA Series Trust held 49,776 shares of XBiotech worth $296K as of Q2 2023.
  • XBiotech was a new EA Series Trust position in Q2 2023.
  • XBiotech made up 0.01% of EA Series Trust's portfolio in Q2 2023, its #966 holding.
  • 39 funds tracked by Wall St. Rank held XBiotech as of Q2 2023.

Based on EA Series Trust's 13F filing for Q2 2023, filed 27 Jul 2023.